摘要:
The object of the present invention is to provide a therapeutic agent for osteoporosis with a good bone mass-increasing effect, but almost no blood calcium-increasing effect. The present invention provides a therapeutic agent for osteoporosis which comprises, as an active ingredient, a compound of Formula (1): wherein
R 1 and R 2 each represent a hydrogen atom or a methyl group, R 3 represents a C 1 -C 4 alkyl group which may be substituted with a fluorine atom, m represents an integer of 0 to 3, and A represents -CH 2 -CH 2 -, -CH=CH- or -C≡C-.
摘要:
The present invention relates to crystalline forms of the compound represented by Formula (XI), which is useful for preventing or treating diabetes.
摘要:
Vitamin D derivatives having general formula (1) which are hydroxylated at the 24-position and considered as one of metabolites of physiologically active vitamin D derivatives substituted at the 2β-position wherein R1, R2, R3 and R4 are the same or different and each represents hydrogen or a protective group; X and Y represent each H or OR5, provided that Y is OR5 when X is H, and Y is H when X is OR5 (wherein R5 represents hydrogen or a protective group, or R1 and R5 may together form a vicinal-diol protective group); synthesis intermediates useful in synthesizing these vitamin D derivatives; and medicinal compositions containing these vitamin D derivatives.
摘要:
Provided are vitamin D derivatives which exhibit excellent physiologic activities suitable for drugs, particularly remedies for dermatoses such as psoriasis, and are lowered in the calcium increasing activity. The derivatives are represented by the general formula (1): (1) wherein X is oxygen or sulfur; m is a number of 1 to 3; R1 and R2 are each hydrogen or alkyl; R4 and R5 are each hydrogen, hydroxyl, or the like; R3 is YR8 or the like; R6 is hydrogen or the like; and R7 is hydrogen or the like.
摘要:
There are provided a novel process for producing [{(5Z,7E)-(1S,3R,20S)-1,3-dihydroxy-9,10-secopregna-5,7,10(19),16-tetraen-20-yl}oxy]-N-(2,2,3,3,3-pentafluoropropyl)acetamide, which process is characterized by irradiating a compound represented by the formula:
with UV to ring-open the compound, and then isomerizing the resulting compound; an intermediate useful for carrying out the process; and a process for producing the intermediate.
摘要:
There are provided a novel process for producing [{(5Z,7E)-(1S,3R,20S)-1,3-dihydroxy-9,10-secopregna-5,7,10(19),16-tetraen-20-yl}oxy]-N-(2,2,3,3,3-pentafluoropropyl)acetamide, which process is shown in the following reaction scheme:
an intermediate useful for carrying out the process, and a process for producing the intermediate.